chrisvoncsefalvay/vaers-outcomes huggingface dataset:
their mom and dad felt haziness in their brain; This is a spontaneous report from a contactable consumer. This consumer reported for female patient (Person's mom) that the female patient with unspecified age received BNT162B2 (Pfizer-Biontech Covid-19 Vaccine, formulation: Solution for injection, batch/lot number: unknown) via unknown route of administration on an unknown date as DOSE NUMBER UNKNOWN, SINGLE for COVID-19 immunisation. The patient medical history and concomitant medications were not reported. On an unknown date, it was stated that another person from work said their mom and dad felt haziness in their brain when they got the Pfizer vaccine. The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2], was not provided and would be requested during follow up.
Sat morning, Papular rash starting on back of neck, spread to rest of body, also present during physical exam on 07/23/07. Injection site swollen, erythrimatic. Pt was also on antibiotic therapy at the time.
I received the Shingrix Vial Kit vaccination for shingles. My arm is very sore.  It is red, hot, and swollen.  My body aches.  I have had a severe headache that requires both Tylenol and Advil to make it bearable.
Fever,Headache ,Body Aches , Tired, Arm hard  ,Itchy and EVERY RED, Chills, Diarrhea  ringing in right ear became much worse( louder) . Have an issue with Tinnitus but now is worse. 7 days later ( today) still have pain in right arm with redness, headache Diarrhea,  some Body Aches.
Part of my face was drooping; Joint pain. I was diagnosed with Rheumatoid Arthritis in August 2021.
Pt fainted head first upon walking out of the store. Called 911 and the medical team assessed the patient.
Friday noc 20MAY94 fever 102.5; APAP given; vomited x 2 post ER advised APAP; diarrhea loose stools x 4 a day since 17MAY94; ER called sun noc; MD owed sx to shots; ordered pedialyte x 4 hrs; prescribed amoxil for LOM-sore throat;
Right arm swollen, hot from shoulder to elbow. Mother states child complained of soreness and itching.
I have been having fever, chills, gastrointestinal issues. I have been using hot and cold packs on my arm as it has been extremely sore. I have been coughing with mucus production, chest congestion, using my inhaler to help me breathe when I need it. I have used a home COVID-19 test twice that has come back negative. My GI doctor did prescribe me hyoscyamine 0.1mg to help with the gastrointestinal issues, I am also taking ZOFRAN to help with the nausea. Currently I am feeling bloated, nauseated, trying to eat but I feel crampy. I am waiting on the doctor to call me to give me the test results of the lab work.
tingling feelings and cooling feeling in arms, legs, and face; tingling feelings and cooling feeling in arms, legs, and face; chills; nausea; fatigue; This is a spontaneous report from a contactable consumer (patient) reported for self via Pfizer sales representative. A 46-year-old female patient received second dose of bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tingling feelings and cooling feeling in arms, legs, and face; chills, nausea, and fatigue. Events took place after use of product. Not painful and no eruptions same day as receiving 2nd dose of the vaccine. The outcome of events was unknown.   No follow up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Developed ITP on 3/29/04 with diffuse petechial rash and platelet count of 15,000. Patient admitted for 1 day to hospital for IVIG therapy. Nurse follow up on 05/12/04: "None".
Client received vaccination around 2:15 pm and around 2:30 pm felt dizzy. Client laid back a little, drank water, and had crackers. After about 5 minutes she was feeling less dizzy, but then became upset, most likely due to anxiety as reported by client. Around 2:40 pm, client complained of chest tightness and pain. Vitals were taken. Oxygen saturations were 95%, heart rate was 97, and blood pressure was 116/70. Client stated that she had similar symptoms yesterday and laying down helped, but it was hard to lay down because she was in a wheelchair and couldn't tip very far back. The chest pain and tightness were not improving so an ambulance was requested at 2:45 pm. At 2:54, client said that the chest pain and tightness was a little worse. Client complained of a little throat tightness and feeling hot at 3:00 pm. Client complained of a headache at 3:05 pm and feeling weak at 3:07 pm. There were no visible signs of distress and client was able to take breaths whenever asked. Around 3:15 pm the ambulance arrived and took over. Client left in the ambulance around 3:22 pm. The EMTs thought it was most likely an anxiety/panic attack.
pt recv vax;bad asthma attack;achy all over;had numbness in rt leg;never had adverse rxn w/ previous flu shots;to call MD in pm & advised hlth dept of result;
Right injection site arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Right injection site arm was sore) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037F21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Right injection site arm was sore). At the time of the report, VACCINATION SITE PAIN (Right injection site arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Severe upper abdominal pain, wrapping around to back left side and eventual Diagnosis of Acute Pancreatitis. Cause is unknown as I am not an alcoholic, do not have a gallbladder or gall stones and current medications do not cause it.  Pain and treatment are still ongoing since April 19.  Had 4 Emergency Room visits between April 26 and June 15 and was hospitalized for it on June 15.
Patient received injection and walked to observation area. Upon sitting down patient complained of dizziness and feeling very tired. Patient leaned back in their chair and became unresponsive upon questioning. At this point 911 was called and an ambulance was dispatched. It appeared patient was unconscious for a short period of time (5-10 seconds) and failing to respond to questions. Pt was experiencing mild diaphoresis. Pulse and breathing were being manually monitored. Patient seemed to regain consciousness however was still not answering our questions. Patient was then able to sit up and very slowly (taking many breaks) was able to walk (with assistance) to an observation room closer to the doorway. Paramedics loaded patient onto stretcher and took patient to hospital.
Patient states she noticed a little discomfort and itching on 5/21/14 around 5 p.m. On 5/22/14 patient came in for a Mantoux reading and asked about the reaction. The redness was 6cm by 5cm with induration. No other symptoms.
Pain; Rash; This case was reported by a consumer and described the occurrence of pain in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   In September 2019, the patient received Shingrix. In November 2019, between 1 and 3 months after receiving Shingrix, the patient experienced pain and rash. On an unknown date, the outcome of the pain and rash were unknown.   It was unknown if the reporter considered the pain and rash to be related to Shingrix.  Additional case details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per the vaccine indication. The patient received Shingrix vaccine in September 2019 and experienced Pain and rash recently in November 2019. The reporter was enquiring whether the patient can get shingles in between the administering of the 2 vaccines or not.
Blood boil in the mouth on left cheek in the mouth which burst; This is a spontaneous report from a contactable consumer (patient). A 79-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EN6202, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 28Feb2021 12:15 (at the age of 79-years-old) as 2nd dose, single dose for COVID-19 immunisation. Medical history included penicillin allergy, sulpha allergy and heart disease from an unknown date. The patient's concomitant medications were not reported. Prior to vaccination, the patient has not been diagnosed with COVID-19. The patient didn't receive any other vaccines within 4 weeks prior to COVID vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot number: EN6201, Expiration date was not reported), via an unspecified route of administration (administered on the left arm) on 07Feb2021 18:00 (at the age of 79-years-old) for COVID-19 immunisation. The patient experienced blood boil in the mouth on left cheek in the mouth which burst on 01Mar2021 15:00. No treatment was received for the event. Since the vaccination the patient has not been tested for COVID-19. The outcome of the event was recovering.  No follow-up attempts are possible. No further information expected
Chills, myalgias, rash to chest and ear that is pruritic (started day after the vaccine and continued to day 3 post vaccine). No signs of anaphylaxis.
This spontaneous case, initially received on 02-Nov-2016, was reported by a health professional and concerns a 69 year old patient. Weight: not provided; Height: not provided. Concomitant medication: Not reported. Administration of company suspect drug(s): On 16-Sep-2016 the patient received AFLURIA. Dose regimen: Not reported, Route of administration: Intramuscular, Batch number: WT54306. No additional suspect drugs. Adverse event description: On 23-Sep-2016, a nurse reported that a refrigerator went in and out of (temperature) range while there was flu vaccine in it. On 19-Sep-2016, doses were administered (special circumstances: drug administration error without adverse event, incorrect product storage without adverse event). Flu vaccine was first delivered to the vaccination facility on 15-Aug-2016. As the nurse reviewed the refrigerator temperature log, she stated that another excursion occurred on 15-Sep-2016. The doses arrived at 09:00 and were placed in a refrigerator that was at 10 degrees Celsius in the morning. Then the temperature remained at 9 degrees Celsius throughout the 15th and 51 doses were administered on the 16th at a flu clinic. The refrigerator was not back in range until 19-Sep-2016 at a temperature of 8 degrees Celsius. Temperature excursion identified: Log documentation reflected temperature excursions from 31-May-2016 to 23-Sep-2016 which ranged between 8 to 10 degrees Celsius. Vaccines had been given to patients between 31-May-2016 and 23-Sep-2016. On 04-Oct-2016, the remaining 42 doses of lot number WT54306 were discarded. The patients will be contacted for revaccination.
p/vax pt devel pruritus & began on arms & back of knees, spread over entire body. rash continues to worsen. treated w/prednisone
pt recvd vax & 20-30 mins later exp hypotension, faint, flushing, diaphoresis, & euphoria; This is considered an invalid case;
Passed out right after yellow fever shot given. Provided all necessary treatment. Dr. aware. V/S taken every 15 mins. All vital signs within normal limits. Vomited X 3 and Passed out X3. Pt felt better after vomiting. Pt was able to take sips of water and alert prior to leaving. Did escort patient out by wheelchair and father at patient side. Dr. did see patient prior to leaving. Encouraged to take it easy and rest for the rest of the day. The site of the shots no concerns noted.
Information has been received from a pharmacist referring to a 52 year old female patient. The patient was allergic to sulfonamides, propoxyphene, nonsteroidal anti-inflammatory drugs (NSAIDs), zafirlukast, codeine and codeine derivatives. The patient had no pertinent medical history. On 20-NOV-2015, the patient was vaccinated with a dose of ZOSTAVAX, 0.65 ml once (lot# and expiration date unspecified) subcutaneously. Concomitant therapies included alprazolam, promethazine, PROAIR, SYMBICORT, hydrochlorothiazide (manufacturer unknown), CONCERTA, losartan potassium (manufacturer unknown), clonidine, montelukast sodium (manufacturer unknown) and metformin. On 20-NOV-2015, after receiving ZOSTAVAX, the patient developed injection site swelling, which grew to an area of "6 by 6 inches". The patient called to the pharmacist to seek unspecified medical attention. No treatment was given for the event. No other lab diagnostics studies were performed. At the reporting time, the swelling had begun to improve and had reduced to an area of "3 by 3 inches". Additional information has been requested.
FEVER OF 102 F. RASH ON THE LEFT ARM. HARD LUMP ON THE LEFT ARM. ARM PAIN.
She started with loss of taste in middle of June and it is still there.; After receiving 2nd dose, when she was coming back she fell again; She had imbalance of left side of knee; This spontaneous case was reported by a consumer and describes the occurrence of FALL (After receiving 2nd dose, when she was coming back she fell again) and BALANCE DISORDER (She had imbalance of left side of knee) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 019B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.  Concomitant products included ACETYLCYSTEINE, CALCIUM LEVOMEFOLATE, MECOBALAMIN (CEREFOLIN NAC [ACETYLCYSTEINE;CALCIUM LEVOMEFOLATE;MECOBALAMIN]) and VITAMINS NOS for an unknown indication.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced FALL (After receiving 2nd dose, when she was coming back she fell again) (seriousness criterion medically significant) and BALANCE DISORDER (She had imbalance of left side of knee) (seriousness criterion medically significant). On an unknown date, the patient experienced AGEUSIA (She started with loss of taste in middle of June and it is still there.). The patient was treated with IBUPROFEN ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, FALL (After receiving 2nd dose, when she was coming back she fell again) and BALANCE DISORDER (She had imbalance of left side of knee) outcome was unknown and AGEUSIA (She started with loss of taste in middle of June and it is still there.) had not resolved.            Patient had bunch of tests done in April with Neurologist.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   This case was linked to MOD-2021-269894 (Patient Link).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Multiple times I have sought out medical attention for a respiratory illness that prevented me from normal daily activities. Symptoms were: Fever. Body aches, shortness of breath, Uncontrollable coughing. Chills/night sweats. Exhaustion. Sever sore throat with swollen lymph nodes. Ear Congestion (No where else) Each time these symptoms last for about 2 to 3 weeks at a time and sought out medical attention about 1 week into the illness.   *I don't normally get sick often. Maybe once a year with the change of seasons. Even rare when I am so sick I can't perform daily activities. Since the vaccine I have been ill with respiratory related illness at least 3-4 times since the shot. The last couple times I sought medical attention from Emergency room visits with a follow up from my doctor.  I was given Benzonate for cough. Azythromyacin tablets as well as cephalexin and sudafed.
After vaccinating, light headed and a little swelling in throat but says it happens out of the blue to him at times. Took Claritin and was fine. O2 sat 98%.
After holding baby on shoulder mom lowered baby to a sitting position in her lap.  Baby began "shaking all over, legs, arms and head", "eyes seemed to be staring".  Episode lasted about 30 seconds according to mom.  "Seemed fine afterward" but vomited 10 min. later and fell asleep (baby had just previously been fed).
RASH LOWER AND UPPER EXT MACULOPAPULAR RASH NONITCHING, NONTENDER, STARTED TWO WEEKS AFTER VACCINE ONGOING NOW FOR THREE WEEKS WORSE ON LEG OF INJECTION
Child had a questionable febrile seizure 1/27/18. Was taken to the ER. An MMR was ordered and MMRV was given in error. This was not discovered until a monthly vaccine audit. The child also had a history of a febrile seizure 1/11/2018.
Chills ,,,,, Aches and pain ?. Headache     Rapid Heart Beat Dizziness'
This happened twice fever went up to 102 for few hours. After going to sleep went away. I went to urgent care nothing seem out of place(lab results).
Breakthrough Case of COVID-19. I started having sharp pains in my stomach. I called the advice nurse and was told it was normal. I didn't have any other symptoms. I was in contact with my boyfriend that contracted COVID-19 from work. I tested multiple times at a community center and showed negative. I took a home test and it showed it was positive. I then, went to drive-thru clinic and tested positive for COVID-19. I lost my sense of taste and smell for three or four days. My symptoms were mild and lasted five days.
Began getting really tired in the evening on the same day as the shot.  Could not sleep for 2 nights.  Really sore (body aches) and bad headaches.  Arm where injection was give very sore.
SICKNESS; This spontaneous report received from a health care professional concerned a 34 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received combination product golimumab (solution for injection in pre-filled pen, subcutaneous, batch number was not reported) dose and frequency were not reported from AUG-2019 for an unspecified indication. Product constituent parts included smartject (route of admin, lot, serial number, model number, UDI number, and expiration were not reported). The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 01-DEC-2021, the patient experienced sickness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and treatment with golimumab was withdrawn. The outcome of sickness was not reported. This report was non-serious.
Scattered fluid, filled (vesicles) pink head, legs, abdomen ~ 5-10.
Typhim Vi was administered to an underage patient in the left thigh with no reported adverse event; Initial information received on 07-Dec-2022 regarding an unsolicited valid  non-serious case received from other health professional.  This case involves a 18 months old male patient who experienced typhim vi was administered to an underage patient in the left thigh with no reported adverse event after receiving vaccine TYPHOID VI POLYSACCHARIDE VACCINE [TYPHIM VI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included RABIES VACCINE INACT (CHICK EMBRYO) (RABAVERT).  On 07-Dec-2022, the patient received a (Series: N/A) suspect TYPHOID VI POLYSACCHARIDE VACCINE(Dose- 0.5mL)(Frequency-Total)(Formulation-Solution for injection) via unknown route (Batch/lot number -U2A292V)(Expiry Date-30-Sep-2023) in the left thigh for Immunization    On 07-DEC-2022 the patient developed a non-serious event typhim vi was administered to an underage patient in the left thigh with no reported adverse event (product administered to patient of inappropriate age) following the administration of TYPHOID VI POLYSACCHARIDE VACCINE.( Latency- Same day)  It was reported The safety and immunogenicity of Typhim Vi vaccine in children under two years of age has not been established. As with other polysaccharide vaccines, the antibody response may be inadequate. The decision whether to vaccinate children under 2 years of age depends upon the risk incurred by the child on the basis of the epidemiological context.  Action Taken : not applicable.  At time of reporting, the outcome was Unknown for the event typhim vi was administered to an underage patient in the left thigh with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
pt recv vax & devel an inj site rxn characterized by redness, swelling, warmth, & tenderness;pt was improving 48hr p/vax & given pneumococcal vax;
The caller reports the consumer has shown no side effects to the vaccines administered; PROQUAD Dose/Frequency: Once, possibly twice; This spontaneous report was received from a consumer referring to of a nine-year-old female patient. Her pertinent medical history, concomitant drugs and drug allergies were not reported. The caller reports vaccine history of the consumer was unknown because the consumer was not in the country before age one or two.   On 23-APR-2021, patient was vaccinated with an unknown vaccine, from an unknown manufacturer, which is suspected to have been a vaccine for Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (manufacture unknown) (lot #, expiration date, dose, strength, and route were not reported) for prophylaxis. However, there was no documentation of this vaccine, so it was unknown exactly what it included, what it was for, or what company manufactured it.  On 04-MAY-2021, the patient "following CDC guidelines for catchup vaccines," was administered with which they would be considering as the first dose of Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) (lot #, expiration date, dose, strength, and route were not reported) for prophylaxis. She was vaccinated with a total of six vaccines including Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live (PROQUAD) that day. Reporter refused to say what the other five vaccines were.  The caller reports the consumer has shown no side effects to the vaccines administered 04-MAY-2021. Consent to contact the caller and the consumer's physician was denied, with the exception of emailing the caller a copy of the prescribing information. No additional adverse events or product quality complaints were reported.